Michael O'LearyCombination treatment shows promise for rare, fatal cancers CANCER DIGEST – Nov. 17, 2024 – Researchers at UCLA have found that combining an immunotherapy drug with chemotherapy significantly...
Michael O'LearyNanotechnology for prostate cancer treatment inches toward realityCANCER DIGEST – Oct. 19, 2024 – Using nanotechnology to treat prostate cancer, researchers eliminated tumors in 73 percent of men treated.
Michael O'LearyOlaparib may be sufficient for PSA recurrent prostate cancer among men with BRCA2 alterationsCANCER DIGEST – Aug. 24, 2024 – Men with mutations in a certain gene and whose prostate cancer is recurring as judged by a rising PSA,...